Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Q4 2024 Management View CEO Steve Cutler introduced Barry Balfe as the newly appointed COO, highlighting his 20-year tenure at ICON and focus on strengthening strategic partnerships across the ...

This initiative celebrates the dedication and excellence showcased by visionary leaders and their business ventures.

Austin's status as an emerging hub for life sciences is of particular importance now, because the momentum is expected to help blunt the impact of potentially millions annually in cuts to federal ...

Calley Means, advisor to RFK Jr. locked horns with CNN anchor Pamela Brown and called out an alleged big pharma shill in real time for “conflicts of […] ...

In response to the prospect of a tariff war, representatives of Taiwan’s ruling establishment headed to Washington on February 11 to express their willingness to “work with” the Trump administration.

Great dividend stocks should offer a mix of durability, solid income generation, and growth prospects. Read more to see 2 ...

ICON's fourth-quarter 2024 earnings and revenues beat estimates as it manages to navigate a challenging transition period.

UroGen Pharma (NASDAQ:URGN) stock in focus as company acquires oncolytic virus ICVB-1042 from IconOVir Bio, to design ...

Named to Trade Show Executive’s Fastest 50 and Next 50 lists, these premier events continue to set industry benchmarks for ...